Microsurgical treatment of unruptured middle cerebral artery aneurysms: a large, contemporary experience

Eric S Nussbaum1, Michael T Madison1, James K Goddard1

  • 11National Brain Aneurysm Center, Twin Cities, Minnesota; and.

Abstract

Insights

Microsurgical repair of unruptured middle cerebral artery (MCA) aneurysms demonstrates excellent outcomes. This study found very low complication rates and high success in aneurysm occlusion, supporting microsurgery as a safe and effective treatment option.

Area of Science:

  • Neurosurgery
  • Vascular Surgery
  • Neurology

Background:

  • Endovascular therapies for middle cerebral artery (MCA) aneurysms are advancing.
  • This necessitates a re-evaluation of microsurgical repair's benefits and outcomes.
  • Understanding complication rates is crucial for treatment selection.

Purpose of the Study:

  • To review outcomes of open microsurgery for unruptured MCA aneurysms.
  • To assess complication rates associated with microsurgical repair.
  • To provide data on the efficacy of microsurgical treatment.

Main Methods:

  • Retrospective review of 716 patients with 750 unruptured MCA aneurysms treated between 1997 and 2015.
  • All procedures performed by a single neurosurgeon using techniques like clipping, wrapping, bypass, and parent artery occlusion.
  • Aneurysm occlusion confirmed with intraoperative digital subtraction angiography (DSA) and/or indocyanine green videoangiography.

Main Results:

  • A total of 750 unruptured MCA aneurysms were treated, with 90% by primary clip reconstruction.
  • Surgical morbidity rate was 2.8%, with a mortality rate of 0%.
  • Complete angiographic occlusion was achieved in 92.0% of aneurysms, with most patients having excellent functional outcomes (mRS 0-1).

Conclusions:

  • Microsurgical management of MCA aneurysms in high-volume centers yields very low morbidity.
  • Microsurgical repair remains a highly effective and safe treatment for MCA aneurysms.
  • This approach offers excellent long-term functional outcomes for patients.

Related Concept Videos

Contemporary Psychology01:29

Contemporary Psychology

Psychology explores human behavior and mental processes through various lenses, each offering unique insights. This overview examines key subfields, including biopsychology, evolutionary, developmental, personality, and social psychology, highlighting their approaches and contributions to understanding complex human behaviors.
Biopsychology
Biopsychology, also known as biological psychology or behavioral neuroscience, focuses on the biological underpinnings of behavior and mental processes. It...
2.3K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
618
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
478
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
513
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
437
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
633